ArticleBMC cancer2023

Network meta-analysis of first-line immune checkpoint inhibitor therapy in advanced non-squamous non-small cell lung cancer patients with PD-L1 expression ≥ 50.

Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.